Søgning


Flere søgeindstillinger

Søgning på udtrykket 'spondylodiscitis' giver 9 resultater


Dokumenter [2] Sider [1] Nyt fra tidsskrifterne [5]
Dokumenter [2]

Denne udgave erstatter "guidelines for diagnostik og behandling af spondylodiscitis. 2018" Væsentlige ændringer siden sidste udgave: • Forsimpling af behandlingsvarighed til nu enten 6 eller 12 uger for hhv. ukompliceret eller kompliceret SD. • Tilføjelse af bilag 1-8 med anbefaling af antibiotisk anbefaling for hyppige SD udløsende bakterier • Udførlig beskrivelse af indikation for rifampicin • Anbefaling af PET/CT som 1.

Bl.a. celler i CSV, spondylodiscitis samt dansk infektionsmedicin på den internationale arena

Sider [1]

… 7) Berbari et al. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. CID 2015:61 (15 September). 8) Kehrer et al. Increasing incidence of pyogenic spondylodiscitis: A 14-year population-based study. J infect. 2014;68:33-20. 9) Aagaard T el al. Long-term mortality after staphylococcus aureus spondylodiscitis: A Danish nationwide population-based cohort study. J infect. 2014;69:252-8.

…behandling med antibiotika. Det gælder desværre for nær alle infektioner. Og når der ikke er evidens så må vi sætte vores lid til eksperter (og sagt af en ekspert så nærmer de råd sig det tilfældige). Det franske DTS (Duration of Treatment for Spondylodiscitis) er et stort skrift på vejen til at ændre vores lemfældige anbefalinger på ét område. I Frankrig studerede man i et randomiseret klinisk studie om der var forskel på at behandle spondylodiscitis med antibiotika i 6 eller 12 uger.

Nyt fra tidsskrifterne [5]
International Journal of Infectious Diseases
22.12.2024
Affecting intervertebral discs and adjacent vertebrae, Pyogenic spondylodiscitis is a severe bacterial infection, typically Staphylococcus aureus with or without methicillin resistance [1–3]. It is a hematogenous infection carried from other sites of infection. In most cases, the infection spreads through the bloodstream from the skin, respiratory tract, urinary tract, gastrointestinal tract, or oral cavity, extending from the vertebral cartilage to the intervertebral disc [4].
BMC Infectious Diseases
19.12.2024
. Abstract. Citrobacter youngae (C. youngae) was first described in 1993, and data suggesting that human diseases caused by this bacterium remain scarce. Reports on C. youngae infections mostly described local infections without evidenced bacteremia, especially in immunocompromised patients. Herein, we report a rare case of bacteremia with intervertebral disc and adjacent vertebral infection due to C. youngae (detected by the Vitek® 2 Compact).
Clinical Infectious Diseases
24.04.2024
Abstract . The ESC diagnostic criteria for infective endocarditis (IE) added spondylodiscitis as minor diagnostic criterion. Of patients with Staphylococcus aureus, streptococcal or Enterococcus faecalis bacteremia, 11 of 1807 episodes were reclassified to definite IE of which nine were not treated as IE. Spondylodiscitis as a minor criterion decreases specificity of the criteria.
Clinical Infectious Diseases
27.11.2024
Abstract . Background . Fever is common in infective endocarditis (IE), yet little is known about fever duration in such patients. We aim to identify predictors of persistent fever in patients with suspected IE.Methods . This study was conducted at the Lausanne University Hospital, Switzerland, from January 2014 to June 2023. All patients with suspected IE being febrile upon presentation were included.
BMC Infectious Diseases
12.11.2024
. Abstract. . Background. Tuberculous spondylitis (TS) and brucellar spondylitis (BS) both cause major long-term morbidity and disability. Though Spondylodiscitis is sensitive to magnetic resonance images, some are difficult to differentiate. This study aims to identify specific bone changes on computed tomography (CT) images, further to differentiate TS from BS. . . .

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2025 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.2.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 1.142 s

Cookies og privatliv